On ECHEMI
Home > Drugs > Cerebral hemorrhage
Cerebral hemorrhage
Cerebral hemorrhage, also known as cerebral hemorrhage, has various causes, most of which are caused by rupture of blood vessels due to hypertension and arteriosclerosis, so some people also call it hypertensive cerebral hemorrhage. According to whether it is caused by traumatic factors, it can be divided into traumatic intraventricular hemorrhage and spontaneous intraventricular hemorrhage. The close relationship between cerebral hemorrhage and hypertension is that about 1/3 of patients with hypertension have a chance of cerebral hemorrhage, and about 95% of patients with cerebral hemorrhage have hypertension. Cerebral hemorrhage is a common acute cerebrovascular disease in middle-aged and elderly people, with a high mortality rate and disability rate. It is the clinical type with the highest mortality rate among cerebrovascular diseases in my country. Cerebral hemorrhage accounts for 40% to 50% of all cerebrovascular diseases. 80% of cerebral hemorrhage occurs in the cerebral hemispheres, and 20% occurs in the lobes, brainstem, cerebellum and ventricles.
Related Drugs
Rutin Tablets
Indication: It is mainly used for capillary hemorrhage with increased fragility, and is also used as an auxiliary treatment for hypertensive encephalopathy, cerebral hemorrhage, retinal hemorrhage, hemorrhagic purpura, acute hemorrhagic nephritis, recurrent epistaxis, traumatic pulmonary hemorrhage, postpartum hemorrhage, etc.
Manufacturer:

Yabao PHARMA Sichuan Pharmaceutical Co., Ltd.

Rutin Tablets
Indication: It is mainly used for capillary hemorrhage with increased fragility, and is also used as an auxiliary treatment for hypertensive encephalopathy, cerebral hemorrhage, retinal hemorrhage, hemorrhagic purpura, acute hemorrhagic nephritis, recurrent epistaxis, traumatic pulmonary hemorrhage, postpartum hemorrhage, etc.
Manufacturer:

Shanxi Taiyuan Pharmaceutical Co., Ltd.

Rutin Tablets
Indication: It is mainly used for capillary hemorrhage with increased fragility, and is also used as an auxiliary treatment for hypertensive encephalopathy, cerebral hemorrhage, retinal hemorrhage, hemorrhagic purpura, acute hemorrhagic nephritis, recurrent epistaxis, traumatic pulmonary hemorrhage, postpartum hemorrhage, etc.
Manufacturer:

NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.

Cinnarizine Tablets
Indication: It is used to treat cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, cerebral hemorrhage recovery period, subarachnoid hemorrhage recovery period, sequelae of brain trauma, inner ear vertigo, coronary artery sclerosis and diseases caused by poor peripheral circulation. In recent years, relevant literature reports show that this product can be used for allergic skin diseases such as chronic urticaria and senile skin itching.
Manufacturer:

Tianjin Lisheng Pharmaceutical Co., Ltd.

Cinnarizine Tablets
Indication: It is used to treat cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, cerebral hemorrhage recovery period, subarachnoid hemorrhage recovery period, sequelae of brain trauma, inner ear vertigo, coronary artery sclerosis and diseases caused by poor peripheral circulation. Relevant literature reports in recent years. This product can be used for chronic urticaria. Senile skin itching and other allergic skin diseases.
Manufacturer:

CSPC OUYI Pharmaceutical Co., Ltd.

Cinnarizine Tablets
Indication: It is used to treat cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, cerebral hemorrhage recovery period, subarachnoid hemorrhage recovery period, sequelae of brain trauma, inner ear vertigo, coronary artery sclerosis and diseases caused by poor peripheral circulation. In recent years, relevant literature reports show that this product can be used for allergic skin diseases such as chronic urticaria and senile skin itching.
Cinnarizine Tablets
Indication: It is used to treat cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, cerebral hemorrhage recovery period, subarachnoid hemorrhage recovery period, sequelae of brain trauma, inner ear vertigo, coronary artery sclerosis and diseases caused by poor peripheral circulation. In recent years, relevant literature reports show that this product can be used for allergic skin diseases such as chronic urticaria and senile skin itching.
Manufacturer:

Teyi Pharmaceutical Group Co., Ltd.

Cinnarizine Tablets
Indication: It is used to treat cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, cerebral hemorrhage recovery period, subarachnoid hemorrhage recovery period, sequelae of brain trauma, inner ear vertigo, coronary artery sclerosis and diseases caused by poor peripheral circulation. In recent years, relevant literature reports show that this product can be used for allergic skin diseases such as chronic urticaria and senile skin itching.
Manufacturer:

Hebei Yongfeng Pharmaceutical Co., Ltd.

Cinnarizine Tablets
Indication: It is used to treat cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, cerebral hemorrhage recovery period, subarachnoid hemorrhage recovery period, sequelae of brain trauma, inner ear vertigo, coronary artery sclerosis and diseases caused by poor peripheral circulation. In recent years, relevant literature reports show that this product can be used for allergic skin diseases such as chronic urticaria and senile skin itching.
Manufacturer:

Hebei Yongfeng Pharmaceutical Co., Ltd.

Cinnarizine Tablets
Indication: It is used to treat cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, cerebral hemorrhage recovery period, subarachnoid hemorrhage recovery period, sequelae of brain trauma, inner ear vertigo, coronary artery sclerosis and diseases caused by poor peripheral circulation. In recent years, relevant literature reports show that this product can be used for allergic skin diseases such as chronic urticaria and senile skin itching.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.